Jul. 11 at 4:53 PM
$LLY's blockbuster drugs are firing up sales! 🚀
💊 Mounjaro & Zepbound combined sales reached
$6.15B in Q1 2025, driving nearly half of Lilly’s revenue. International launches and ramped-up production are fueling growth.
Discover the full potential ahead for Eli Lilly here 👉 https://www.zacks.com/stock/news/2573312/can-mounjaro-and-zepbound-drive-another-strong-quarter-for-eli-lilly?cid=sm-stocktwits-2-2573312-body-1326&ADID=SYND_STOCKTWITS_TWEET_2_2573312_BODY_1326